Plain language summary
======================

Home care workers (HCWs), which include home health aides and personal care aides, represent one of the fastest growing sectors of the health care industry and US economy and are increasingly being utilized by home-dwelling adults with heart failure (HF) for long-term assistance and post-hospitalization care. In contrast to physicians or visiting nurses who see HF patients for short periods of time, HCWs are with HF patients on a daily or near-daily basis and sometimes up to 24 hours a day. As such, they assist with many aspects of HF self-care such as meal preparation, taking vital signs, assisting with medication compliance, and accompanying patients to medical appointments. Yet, the role of HCWs in HF has not been characterized. This systematic review is the first to determine the effect of HCWs on HF patient outcomes. Five electronic databases were searched. Study quality was assessed with the Downs and Black checklist. Of the 7,032 studies screened, six met inclusion criteria. Among the six studies, five were observational and one was quasi-experimental. Studies were of poor-to-fair quality, often lacking methodological rigor. While HCWs in HF are common, the literature on them is limited. Additional research is warranted to understand their role in HF management and their effect on health outcomes.

Background
==========

Heart failure (HF) is a complex, chronic disease that requires a high degree of self-care and frequent contact with the health care system.[@b1-jmdh-11-481],[@b2-jmdh-11-481] HF patients often have multiple chronic conditions, functional and cognitive impairments,[@b3-jmdh-11-481] and sensory deficits.[@b4-jmdh-11-481],[@b5-jmdh-11-481] As such, many rely on informal (family) and formal (paid) caregivers to help them manage their disease and navigate the health care system.[@b6-jmdh-11-481]--[@b10-jmdh-11-481]

Formal caregivers are increasingly being used by adults with HF. With the implementation of Medicare payment reforms, including financial penalties for 30-day readmissions, a growing number of adults hospitalized for HF are now discharged with home health care (HHC).[@b11-jmdh-11-481]--[@b13-jmdh-11-481] HHC offers short-term skilled nursing, physical and occupational therapy, speech and language therapy, medical social work, and care from home care workers (HCWs).[@b11-jmdh-11-481]--[@b13-jmdh-11-481]

HCWs, which include home health aides (HHA) and personal care aides (PCA), are one of the fastest growing sectors of the health care industry and US economy.[@b14-jmdh-11-481]--[@b16-jmdh-11-481] While their roles differ, with HHAs receiving more specialized training and having a greater scope of tasks than PCAs,[@b17-jmdh-11-481]--[@b19-jmdh-11-481] both provide physical and emotional support to HF patients.[@b17-jmdh-11-481] HCWs are with patients on a daily or near-daily basis[@b17-jmdh-11-481],[@b20-jmdh-11-481] and are often involved with key aspects of HF maintenance and management including meal preparation, weight and fluid monitoring, medication compliance, and transportation to medical appointments. These interactions may affect outcomes for patients with HF, but the exact influence of HCWs in the context of HF has not been studied.

To fill this gap, we conducted a systematic review of the literature in order to 1) describe utilization patterns of HCWs by adults with HF, 2) examine the effect of HCWs on HF outcomes, and 3) review HF interventions that involve HCWs.

Methods
=======

This systematic review is reported in line with the PRISMA guidance[@b21-jmdh-11-481] and was registered with PROSPERO (CRD42017077405).

Search strategy
---------------

A medical librarian (DD) performed comprehensive literature searches of Ovid MEDLINE (in-process and other non-indexed citations and Ovid MEDLINE from 1946 to present), Ovid EMBASE (from 1974 to present), Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials \[CENTRAL\], and Cochrane Methodology Register), CINAHL (EBSCO), and AgeLine (EBSCO) from inception to August 4, 2017. The first search was conducted in Ovid MEDLINE. Subject headings and key words were adapted for the other databases. No restrictions of language, publication date, or article type were applied. Additional records were identified by reviewing reference lists and employing the "Cited by" and "View references" features in Scopus of the included studies. The full search strategy for Ovid MEDLINE is available in Supplemental material S1.

Inclusion and exclusion criteria
--------------------------------

This review was limited to observational studies, quasi-experimental studies, and randomized controlled trials (RCTs). To be included, studies must have pertained to community-dwelling adults (≥18 years of age) with HF and focused on HCWs, including HHAs, PCAs, and home health attendants. Only studies that were published in English and conducted in the United States were included ([Table 1](#t1-jmdh-11-481){ref-type="table"}).

Qualitative studies, case reports, editorials, reviews, doctoral dissertations, and scientific meeting abstracts were excluded. Studies that focused on home health nurses were excluded, as were those in which HF patients resided in nursing homes, long-term care centers, and acute rehabilitation centers.

Selection of studies
--------------------

[Figure 1](#f1-jmdh-11-481){ref-type="fig"} shows the PRISMA flow diagram of reviewed and included studies ([Figure 1](#f1-jmdh-11-481){ref-type="fig"}). All studies identified following the database search were uploaded to the Web-based systematic review software package Covidence (<https://www.covidence.org/>). First, title and abstract review of all studies were completed independently by two authors (ALS and PBKL). Disagreements were discussed and a third reviewer helped to resolve the discrepancies (MRS). A record was kept of all the studies excluded and the reason for exclusion in Covidence. All of the studies that met the inclusion criteria (13) went through a full-text screening process by the three authors independently (ALS, PBKL, and MRS), and any disagreements on the eligibility of the studies were reviewed by a fourth author (DD).

Data extraction
---------------

Data from the included studies were extracted independently by three authors using a data extraction template. Data extracted from the studies included lead author, study title, year published, study population (design and year/duration) study type, study objective, primary outcome, intervention/control group (if applicable), main result(s), and limitations ([Table 2](#t2-jmdh-11-481){ref-type="table"}). The review team resolved any disagreements regarding study eligibility through group discussion.

Assessment of quality
---------------------

The studies included in this systematic review were evaluated using a quality index proposed by Downs and Black (DB), which examines five subscales that measure reporting, external validity, internal validity (two subscales on bias and confounding), and power.[@b22-jmdh-11-481] The DB scale is a 27-item checklist that was developed to assess quality in clinical trials and was modified, based on previous systematic reviews, to accommodate the characteristics of observational studies ([Table S1](#SD1-jmdh-11-481){ref-type="supplementary-material"}).[@b23-jmdh-11-481]--[@b25-jmdh-11-481] The checklist has a good interrater (*r*=0.75) and test--retest (*r*=0.88) reliability, as well as high internal consistency (KR-20=0.89).[@b22-jmdh-11-481] The maximum score for the modified checklist was 28 since all individual items were rated as yes (=1), no (=0), or unable to determine (=0), with the exception of Item 5, where one could receive a maximum of 2 points. The ranges of scores were grouped into four categories: excellent (26--28 points), good (20--25), fair (15--19), and poor (≤14).[@b24-jmdh-11-481],[@b26-jmdh-11-481]

Data synthesis
--------------

Following data extraction and quality assessment, consideration was given to the appropriateness of conducting a meta-analysis. As the studies were too heterogeneous to combine statistically, the data were synthesized qualitatively.

Results
=======

Study selection
---------------

The PRISMA flowchart is presented in [Figure 1](#f1-jmdh-11-481){ref-type="fig"}. The literature search yielded 9,074 articles, from which 2,042 duplicates were removed, leaving 7,032 articles for review. Of these, 7,019 were excluded based on title and abstract review. Among the 13 full-text articles reviewed, 7 were excluded for various reasons (duplicates \[n=3\], study population \[n=2\], study location \[n=1\], and study design \[n=1\]). Overall, the study reports on six articles.

Description of included studies
-------------------------------

Characteristics of the six included studies are detailed in [Table 2](#t2-jmdh-11-481){ref-type="table"}. The studies were published from 1998 to 2017 in journals that focused on home care and management, nursing, and health services research. The majority (n=5) of the included studies were observational,[@b27-jmdh-11-481]--[@b31-jmdh-11-481] of which two were descriptive in nature[@b27-jmdh-11-481],[@b28-jmdh-11-481] and three used retrospective cohort designs.[@b29-jmdh-11-481]--[@b31-jmdh-11-481] One study was a quasi-experimental study with pre- and post-intervention design.[@b32-jmdh-11-481] There were no RCTs. The majority of patients in these studies were ≥65 years of age and were non-Hispanic white. All six studies focused on HHAs without mention of PCAs or other types of paid HCWs.

Risk of bias
------------

Overall, the quality of the studies was fair to poor, with DB quality scores ranging from 10 to 16 and with a mean score of 12.8 (SD 2.3); four studies[@b27-jmdh-11-481]--[@b29-jmdh-11-481],[@b32-jmdh-11-481] were of poor quality and two[@b30-jmdh-11-481],[@b31-jmdh-11-481] were of fair quality ([Table S2](#SD2-jmdh-11-481){ref-type="supplementary-material"}). The majority (n=5) of studies[@b27-jmdh-11-481]--[@b30-jmdh-11-481],[@b32-jmdh-11-481] utilized small samples from one home care agency or one hospital, and thus their results lacked external validity. One study was missing outcome data[@b32-jmdh-11-481] and several were missing demographic and clinical information on study participants. Two studies[@b27-jmdh-11-481],[@b28-jmdh-11-481] found interesting trends but did not perform statistical analyses to discern whether these trends were statistically significant. Finally, reverse causality limited the validity and generalizability of the three studies that examined the effect of HCWs on readmission rates, since they did not attempt to adjust for HF patients' severity of disease or their caregiving needs.

Utilization patterns of HCW by adults with HF
---------------------------------------------

Two studies (Anderson et al[@b27-jmdh-11-481] and Moulton et al[@b28-jmdh-11-481]) characterized the utilization of HHC services, including HHAs, among adults with HF. Both were descriptive in design, collected data via chart review, derived study samples from single home care agencies, and included HF patients who were ≥65 years of age and insured by Medicare. Data from both studies suggested that HF patients who utilized HHAs were older adults with functional limitations, lived alone, or had an unmet caregiving needs. Notably, Anderson et a.[@b27-jmdh-11-481] found that men had more functional limitations and used HHAs more often than women, although this difference was not tested for statistical significance.

HCW and hospital readmission in HF
----------------------------------

Three studies evaluated the effect of having an HHA on the risk of hospital readmission among adults with HF.[@b29-jmdh-11-481]--[@b31-jmdh-11-481] All used retrospective cohort designs, although the sample size varied greatly among the three studies.

A study by Hoskins et al[@b29-jmdh-11-481] included 117 patients who received HHC from one large, nonprofit, Medicare/Medicaid-certified home care agency following an HF hospitalization.[@b29-jmdh-11-481] Overall, 27% of the sample were readmitted. Those who remained at home had more HHA visits (mean\[SD\] 19\[17.5\]) compared with those who were readmitted (14\[11.9\]), but this difference was not statistically significant. Instead, patients' number of prior hospitalizations and their medication burden were significantly associated with greater readmission risk.

Russell et al[@b30-jmdh-11-481] examined the effect of a transitional care program on readmission risk among patients discharged home with home care services following an HF hospitalization from a nonprofit medical/surgical hospital.[@b30-jmdh-11-481] A total of 223 patients received the transitional care program (n=223) while 224 medically similar patients received usual home care services. Overall, 28% of patients were readmitted to the hospital within 30 days. Patients who received the program were 43% less likely to be readmitted to a hospital compared with those who received usual home care services, after adjusting for demographic, clinical, and home care characteristics (adjusted OR 0.57 \[95% CI 0.38, 0.87\]). Notably, there were no differences in readmission by HHA use.

Madigan et al[@b31-jmdh-11-481] used a national sample of 74,580 HHC patients with HF who received home care services in order to identify which patient, geographic, and home care agency factors were associated with 30-day readmissions.[@b31-jmdh-11-481] Overall, the 30-day readmission rate was 26%. Patient-level factors influenced readmission risk the most, when compared with geographic and home care agency factors. Receiving any HHA visit was independently associated with higher likelihood of readmission (OR 1.07 \[1.02, 1.12\]) and shorter time to readmission (HR 1.32\[1.09, 1.28\]) in multivariable analyses.

HF interventions involving HCWs
-------------------------------

A quasi-experimental study by Russell et al[@b32-jmdh-11-481] determined the effect of an HHA-delivered coaching intervention on HF patients' self-care maintenance and quality of life (QoL).[@b32-jmdh-11-481] Participants who received home health services post discharge served as their own controls pre and post intervention. HHAs provided weekly support and HF self-care information to patients during home visits and telephone calls. Health-related QoL and HF self-care were assessed with validated instruments.[@b33-jmdh-11-481]--[@b35-jmdh-11-481] While QoL scores did not differ significantly, participants' HF self-care maintenance scores, as measured by the Self-Care of Heart Failure Index,[@b35-jmdh-11-481] improved significantly (74.4 \[7.1\] vs 66.2 \[12.1\], *P*=0.01) after HHA coaching.

Discussion
==========

Although HCWs frequently care for community-dwelling adults with HF in the United States, our findings demonstrate a paucity of literature that explicitly investigates HCWs in the context of HF self-care and outcomes. A few studies examined the effect of HCWs on the risk of readmission; however, the results were conflicting. Remarkably, only one study incorporated HCWs into an HF intervention. Neither of the studies mentioned PCAs, who comprise 50% of agency-employed HCWs, nor did any of the studies mention non-agency-employed HCWs, of which there are currently 8,00,000 in the United States.[@b19-jmdh-11-481],[@b20-jmdh-11-481]

Because we reviewed observational and quasi-experimental studies (without RCT-level evidence) which were of fair to poor quality, our findings must be interpreted with caution. The studies that examined HCW utilization patterns utilized small and homogeneous patient populations and were conducted two decades ago. The studies that examined the effect of HCWs on hospital readmission used larger, more diverse patient samples, but were methodologically limited.[@b36-jmdh-11-481] That is, HF patients who receive HCWs at discharge are often sicker and have more caregiving needs than those who do not. Thus, without accounting for this, the association between HCWs and readmission risk cannot be carefully isolated. One study used a quasi-experimental approach to determine the effect of HCW-delivered intervention on HF patients' self-care abilities and QoL; however, there was no control group, the sample was small, and dropout rates were high. Overall, our findings call for additional high-quality observational and experimental research to examine the role and effect of HCWs in HF.

To our knowledge, our systematic review is the first to evaluate the peer-reviewed literature on HCWs in HF. Prior reviews have examined the role and impact of other health care professionals on HF patients' outcomes, particularly in the post-discharge period. A systematic review and meta-analysis by van Spall et al[@b37-jmdh-11-481] evaluated RCTs that examined the effect of home-based, nurse-led visits during the post-discharge period on HF patients' health outcomes.[@b37-jmdh-11-481] Compared with usual care, nurse-led interventions offered the greatest reduction in mortality (RR 0.81 \[95% CI 0.63, 1.03\]) and readmission (RR 0.65 \[95% CI 0.49, 0.86\]). This finding is similar to reviews by Feltner et al, Philips et al, and Slyer et al, which also found post-discharge nurse-led visits in HF patients' homes to be effective.[@b38-jmdh-11-481],[@b39-jmdh-11-481],[@b45-jmdh-11-481] Beyond the benefits of single health care professionals, studies have found that multidisciplinary team-based interventions in HF patients' homes reduce hospitalization and readmission rates.[@b40-jmdh-11-481],[@b41-jmdh-11-481] The team members cited in these studies include nurses, advanced HF nurses, pharmacists,[@b42-jmdh-11-481],[@b43-jmdh-11-481] dieticians, physical therapists,[@b44-jmdh-11-481] social workers, primary care providers, and cardiologists.[@b44-jmdh-11-481] Notably absent from this list are HCWs, who, apart from family caregivers, spend the most amount of time with HF patients in the home.

Strengths and limitations
-------------------------

The strengths of our study include the rigorous literature search across several databases, using predefined search terms and strict inclusion and exclusion criteria. Additionally, quality was assessed with the DB checklist, a well-validated tool.[@b22-jmdh-11-481] Some limitations should also be noted. Given that so few quantitative studies exist in this area, our exclusion of qualitative studies may have limited our understanding of the role of HCWs in HF. Additionally, due to the heterogeneous nature of the studies, a meta-analysis was unable to be conducted.

Conclusion
==========

We conducted this systematic review in order to describe utilization patterns of HCWs by adults with HF, examine the effect of HCWs on HF patients' health outcomes, and review HF interventions that involve HCWs. Our findings suggest that despite their widespread use among community-dwelling adults with HF, the literature on HCWs in HF is limited. Due to the paucity of research in this area and the lack of high-quality studies reviewed here, additional and more rigorous research is warranted on the potential role of HCWs in improving QoL and decreasing avoidable health services utilization in HF.

Data sharing statement
======================

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. We have, however, provided our search strategy as this may be helpful to reviewers and readers who wish to reproduce our results (Supplemental material S1).

Supplementary materials
=======================

**Supplemental material S1** Search strategy Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) 1946 to Present Search ran on August 4, 2017 Home Health Aides/Home Care Services/House Calls/(home adj3 (aide\* or care or nurse\* or nursing or service\* or visit\* or worker\* or attendant\* or agencies or program or programme)).mp.(domestic health care or domiciliary care).mp.house call\*.mp.or/1-6exp Heart Failure/(heart failure or asystole or asystolia or asystoly or Cardiac asthma or cardiac arrest or cardiac backward failure or cardiac decompensation or Cardiac Edema\* or Cardiac Failure or cardiac incompetence or cardiac insufficiency or cardiac stand still or Cardio Renal Syndrome\* or cardiorenal syndrome\* or cardiogenic shock or cardiopulmonary insufficiency or cardiorespiratory arrest or cardiorespiratory collaps or cardiorespiratory failure or cardiovascular shock or chronic heart insufficiency or circulation arrest or circulatory arrest or decompensatio cordis or diastolic dysfunction or diastolic overload or forward failure or heart arrest or heart backward failure or heart decompensation or heart incompetence or heart insufficiency or heart left ventricle outflow tract obstruction or heart right ventricle outflow tract obstruction or heart outflow tract obstruction or heart overload or heart shock or heart standstill or heart ventricle failure or high cardiac output failure or high heart output failure or high output cardiac failure or high output failure or high output heart failure or nsufficientia cardis or insufficientia ventriculi or insufficientia ventriculi cordis or low cardiac output or low heart output or myocardial failure or myocardial insufficiency or Paroxysmal Dyspnea\* or PRIS or propofol infusion syndrome\* or propofol related infusion syndrome\* or Renocardiac Syndrome\* or Reno-Cardiac Syndrome\* or Reno Cardiac Syndrome\* or systolic dysfunction or systolic overload or ventricular insufficiency or ventricular overload or ventricle insufficiency or ventricle overload).mp.or 9and 10

###### 

Downs and Black 27-item Checklist

  Checklist question                                                                                                                                                                                                                 Scoring                                                                                                                                                                          
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------
  **Reporting**                                                                                                                                                                                                                      1\) Is the hypothesis/aim/objective of the study clearly described?                                                                                                              Yes = 1; No = 0
  2\) Are the main outcomes to be measured clearly described in the introduction or methods section?                                                                                                                                 Yes = 1; No = 0                                                                                                                                                                  
  3\) Are the characteristics of the patients included in the study clearly described?                                                                                                                                               Yes = 1; No = 0                                                                                                                                                                  
  4\) Are the interventions of interest clearly described?                                                                                                                                                                           Yes = 1; No = 0                                                                                                                                                                  
  5\) Are the distributions of principal confounders in each group of patients to be compared clearly described?                                                                                                                     Yes = 2; Partially = 1; No = 0                                                                                                                                                   
  6\) Are the main findings of the study clearly described?                                                                                                                                                                          Yes = 1; No = 0                                                                                                                                                                  
  7\) Does the study provide estimates of the random variability in the data for the main outcomes?                                                                                                                                  Yes = 1; No = 0                                                                                                                                                                  
  8\) Have all important adverse events that may be a consequence of the intervention been reported?                                                                                                                                 Yes = 1; No = 0                                                                                                                                                                  
  9\) Have the characteristics of patients lost to follow-up been described?                                                                                                                                                         Yes = 1; No = 0                                                                                                                                                                  
  10\) Have actual probability values been reported (eg, 0.035 rather than \<0.05) for the main outcomes, except where the probability value is \<0.001?                                                                             Yes = 1; No = 0                                                                                                                                                                  
  **External validity**                                                                                                                                                                                                              11\) Were the subjects asked to participate in the study representative of the entire population from which they were recruited?                                                 Yes = 1; No = 0; Unable to determine = 0
  12\) Were those subjects who were prepared to participate representative of the entire population from which they were recruited?                                                                                                  Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  13\) Were the staff, places, and facilities where the patients were treated representative of the treatment the majority of patients receive?                                                                                      Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  **Internal validity -- bias**                                                                                                                                                                                                      14\) Was an attempt made to blind study subjects to the intervention they have received?                                                                                         Yes = 1; No = 0; Unable to determine = 0
  15\) Was an attempt made to blind those measuring the main outcomes of the intervention?                                                                                                                                           Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  16\) If any of the results of the study were based on "data dredging," was this made clear?                                                                                                                                        Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  17\) In trials and cohort studies, do the analyses adjust for different lengths of follow- up of patients, or in case--control studies, is the time period between the intervention and outcome the same for cases and controls?   Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  18\) Were the statistical tests used to assess the main outcomes appropriate?                                                                                                                                                      Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  19\) Was compliance with the intervention(s) reliable?                                                                                                                                                                             Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  20\) Were the main outcome measures used accurate (valid and reliable)?                                                                                                                                                            Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  **Internal validity -- confounding (selection bias)**                                                                                                                                                                              21\) Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case--control studies) recruited from the same population?   Yes = 1; No = 0; Unable to determine = 0
  22\) Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case--control studies) recruited over the same period of time?                                               Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  23\) Were study subjects randomized to intervention groups?                                                                                                                                                                        Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  24\) Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable?                                                                                 Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  25\) Was there adequate adjustment for confounding in the analyses from which the main findings were drawn?                                                                                                                        Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  26\) Were losses of patients to follow-up taken into account?                                                                                                                                                                      Yes = 1; No = 0; Unable to determine = 0                                                                                                                                         
  **Power**                                                                                                                                                                                                                          27\) Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%?               Yes = 1; No = 0; Unable to determine = 0

**Notes:** The Downs and Black Checklist is a 27-item methodological quality assessment tool of randomized and nonrandomized studies of health care interventions. The maximum score is 28 since all individual items were rated as yes (=1), no (=0), or unable to determine (=0), with the exception of Item 5, where a maximum of 2 points could be received. Scores are grouped into four categories: excellent (26--28 points); good (20--25); fair (15--19); and poor (≤14).

###### 

Downs and Black quality assessment of the included studies

  Author, year of publication                 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27
  ------------------------------------------- --- --- --- --- --- --- --- --- --- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  **Anderson et al 1998[@b46-jmdh-11-481]**   1   1   1   0   0   1   0   0   0   0    1    0    1    0    0    1    0    1    0    1    0    1    1    1    0    0    0
  **Moulton et al 1998[@b47-jmdh-11-481]**    1   1   1   0   0   1   0   0   0   0    0    1    0    0    0    1    0    1    0    1    1    1    0    0    0    0    0
  **Hoskins et al 1999[@b48-jmdh-11-481]**    1   1   1   0   0   0   1   0   0   1    1    1    0    0    0    1    0    0    0    1    1    1    0    0    0    1    0
  **Russell et al 2011[@b49-jmdh-11-481]**    1   1   1   1   1   0   1   0   1   0    0    1    0    0    0    1    0    1    1    1    1    0    0    0    1    0    1
  **Madigan et al 2012[@b50-jmdh-11-481]**    1   1   1   0   1   1   1   0   0   1    1    0    1    0    0    1    1    1    0    1    1    1    0    0    1    0    1
  **Russell et al 2017[@b51-jmdh-11-481]**    1   1   1   1   1   1   1   0   0   1    0    0    0    0    0    1    0    1    1    1    1    1    0    0    0    0    0

This study was presented at the Society of General Internal Medicine Annual Meeting in Denver, CO, on April 21, 2018.
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**Notes:** PRISMA flow diagram of reviewed and included studies. The figure was created with web-based systematic review software package Covidence (<https://www.covidence.org/>).](jmdh-11-481Fig1){#f1-jmdh-11-481}

###### 

Systematic review inclusion criteria

  Inclusion criteria
  ----------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Studies of community-dwelling adults (age ≥18 years) with heart failure.
  2\. Studies focusing on HCWs[a](#tfn1-jmdh-11-481){ref-type="table-fn"} or including HCW services as independent variables in models and analyses.
  3\. Studies occurring in the United States.
  4\. English articles.
  5\. Peer-reviewed, full articles.
  6\. RCTs, observational studies (descriptive, cross-sectional, retrospective cohort, prospective cohort), and quasi-experimental studies.

**Notes:**

HCWs may be called home health aides, home health attendants, personal care aides, or home health care paraprofessionals.

**Abbreviations:** HCW, home care workers; RCTs, randomized control trials.

###### 

Characteristic of included studies

  First author/Year                       Title/Journal                                                                                                                                                                                                           Study design and population                                                                                                                                                                                                                                                                                                                                                      Study objective(s)                                                                                                                                                                                      Primary outcome(s)                                                                                                                                                                                                                                                                 Main results                                                                                                                                                                                                                                                                                                                                                                                                                                             Limitations                                                                                                                                        Quality
  --------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------- ---------
  Anderson et al 1998[@b27-jmdh-11-481]   Home care utilization by CHF patients: a pilot study, in *Public Health Nursing*                                                                                                                                        Type: Descriptive study Design: Chart review of 1 year of home care patient records. Inclusion criteria: Primary diagnosis of CHF, ≥2 home visits, care reimbursed by Medicare, ≥65 years of age. Study population: Of the 80 records that met inclusion criteria, 40 were randomly selected to be included in the study.                                                        To determine utilization patterns of CHF patients admitted and discharged from a not-for-profit HHA.                                                                                                    HHC utilization patterns of older adults with HF.                                                                                                                                                                                                                                  The majority of participants were 75--84 years old, white, female, and widowed. Men had more functional limitations and more home health aide visits than women; however, differences were not tested for statistical significance. During a HHC episode, 43% of patients were admitted to the hospital at least once.                                                                                                                                   Small sample Single center Single agency                                                                                                           11
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